Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;47(3):501-511.
doi: 10.1016/j.rdc.2021.04.011. Epub 2021 Jun 10.

Systemic Lupus Erythematosus Classification and Diagnosis

Affiliations
Review

Systemic Lupus Erythematosus Classification and Diagnosis

Martin Aringer et al. Rheum Dis Clin North Am. 2021 Aug.

Abstract

Since the European League Against Rheumatism/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus (SLE) were published, they were externally validated by groups worldwide. In particular, the new criteria worked well also in East Asian and pediatric cohorts. Antinuclear antibodies (ANA) as an entry criterion were critically discussed, but the group of ANA-negative patients is small (<5%) worldwide. Specificity of the criteria is dependent on correct attribution only of those criteria that are not better explained by other causes. Although the classification criteria should not be used for diagnosis, many novel aspects inform diagnostic considerations.

Keywords: Antinuclear antibodies; Classification criteria; Cutaneous lupus erythematosus; Neuropsychiatric SLE; Sensitivity; Specificity; Systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Disclosure The development of the SLE criteria was jointly funded by EULAR and ACR. M. Aringer and S.R. Johnson have acted as co-chairs of the EULAR/ACR classification criteria steering committee. No other conflicts of interest apply to this article.

Similar articles

  • Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus.
    Aringer M, Costenbader K, Johnson SR. Aringer M, et al. Expert Rev Clin Immunol. 2022 Feb;18(2):135-144. doi: 10.1080/1744666X.2022.2033617. Epub 2022 Jan 31. Expert Rev Clin Immunol. 2022. PMID: 35076341
  • European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance.
    Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR. Aringer M, et al. Ann Rheum Dis. 2021 Jun;80(6):775-781. doi: 10.1136/annrheumdis-2020-219373. Epub 2021 Feb 10. Ann Rheum Dis. 2021. PMID: 33568386
  • New lupus criteria: a critical view.
    Aringer M, Johnson SR. Aringer M, et al. Curr Opin Rheumatol. 2021 Mar 1;33(2):205-210. doi: 10.1097/BOR.0000000000000771. Curr Opin Rheumatol. 2021. PMID: 33332888 Review.
  • A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum.
    Jin H, Huang T, Wu R, Zhao M, Wu H, Long H, Yin H, Liao J, Luo S, Liu Y, Zhang Q, Zhang P, Tan Y, Luo S, Huang X, Deng Y, Liao W, Duan L, Chen J, Zhou Y, Yin J, Qiu H, Yuan J, Wang Z, Li M, Wu X, Chen L, Cai L, Huang C, Li Q, Tang B, Yu B, Li X, Gao X, Hu Y, Ren X, Xue H, Wei Z, Chen J, Li F, Ling G, Luo H, Zhao H, Yang S, Cui Y, Lin Y, Yao X, Sun L, Guo Q, Fang H, Zeng K, Deng D, Zhang J, Li Y, Pu X, Liao X, Dang X, Huang D, Liang Y, Sun Q, Xie H, Zeng L, Huang C, Diao Q, Tao J, Yu J, Li Z, Xu H, Li H, Lai W, Liu X, Wu J, Li T, Lei T, Sun Q, Li Y, Zhang G, Huang X, Lu Q. Jin H, et al. Lupus. 2020 Dec;29(14):1854-1865. doi: 10.1177/0961203320959716. Epub 2020 Oct 7. Lupus. 2020. PMID: 33028176
  • 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
    Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. Aringer M, et al. Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5. Ann Rheum Dis. 2019. PMID: 31383717 Review.

Cited by

Publication types

Substances

-